| Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats FH Bazzari, DM Abdallah, HS El-Abhar Molecules 24 (10), 1992, 2019 | 73 | 2019 |
| Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far FH Bazzari, DM Abdallah, HS El-Abhar Current Alzheimer Research 16 (3), 261-277, 2019 | 33 | 2019 |
| BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future? FH Bazzari, AH Bazzari Molecules 27 (24), 8823, 2022 | 32 | 2022 |
| BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders AH Bazzari, FH Bazzari International Journal of Molecular Sciences 23 (15), 8417, 2022 | 27 | 2022 |
| Available Pharmacological Options and Symptomatic Treatments of Multiple Sclerosis FH Bazzari Systematic Reviews in Pharmacy 9 (1), 17-21, 2018 | 21 | 2018 |
| Advances in targeting central sensitization and brain plasticity in chronic pain AH Bazzari, FH Bazzari The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 58, 38, 2022 | 20 | 2022 |
| Medicinal plants for Alzheimer’s disease: An updated review AH Bazzari, FH Bazzari J. Med. Plant. Stud 6, 81-85, 2018 | 13 | 2018 |
| Can we induce lucid dreams? A pharmacological point of view FH Bazzari International Journal of Dream Research 11 (2), 106-119, 2018 | 7 | 2018 |
| Attitudes and Knowledge Regarding the Therapeutic Use of Cannabinoids among Community Pharmacists: A Pilot Cross-Sectional Study in Amman, Jordan FH Bazzari, AH Bazzari Healthcare 11 (5), 694, 2023 | 6 | 2023 |
| Orofacial neuropathic pain: a pharmacological approach FH Bazzari, AH Bazzari South African Pharmaceutical Journal 86 (4), 23-28, 2019 | 4 | 2019 |
| Drug-Induced Delirium: A Mini Review FH Bazzari, AH Bazzari BMH. Med. J 5, 51-56, 2018 | 3 | 2018 |
| Utilizing ChatGPT in Telepharmacy FH Bazzari, AH Bazzari Cureus 16 (1), e52365, 2024 | 2 | 2024 |
| Centrally acting antihypertensive agent Ketanserin potential role in delirium management: A review. FH Bazzari Open Science Journal 2 (3), 2017 | 2 | 2017 |
| Promising Therapeutic Agents: Delta Opioid Receptor Agonists AH Bazzari, FH Bazzari International Annals of Medicine 1 (8), 2017 | 2 | 2017 |
| Chenodeoxycholic acid reduces neuroinflammation and oxidative stress in aluminium chloride-induced rat model of Alzheimer’s disease FH Bazzari, DM Abdallah, HS El-Abhar British Journal of Pharmacology 178 (2), 458, 2021 | 1 | 2021 |
| Comprehensive assessment of demographic and occupational factors influencing burnout amongst community pharmacists in Jordan DZ Alshorman, AH Bazzari, FH Bazzari Pharmacia 71, 1-9, 2024 | | 2024 |
| The Public Perceptions on Wet Cupping Therapy (Hijama) in Saudi Arabia SI Alkhamaiseh, AH Bazzari, AH Al jafari, FH Bazzari Journal of Acupuncture and Meridian Studies 16 (5), 176-182, 2023 | | 2023 |
| Assessing Stigma towards Mental Illness in Relation to Demographics Attitudes and Past Experiences among Pharmacy Students in a Jordanian University Sample AH Bazzari, FH Bazzari Behavioral Sciences 13 (11), 884, 2023 | | 2023 |
| Non-Genetic Risk Factors for Dementia and Alzheimer’s Disease FH Bazzari, AH Bazzari Jordan Medical Journal 57 (3), 206-220, 2023 | | 2023 |
| COVID-19 and Burnout among Community Pharmacists in West Bank - Palestine AH Bazzari, FH Bazzari Journal of the Arab American University 9 (2), 39-52, 2023 | | 2023 |
Amjad BazzariApplied Science Private University在 asu.edu.jo 的电子邮件经过验证
Amjad BazzariApplied Science Private University在 asu.edu.jo 的电子邮件经过验证